Inactive Instrument
ISR Immune System Regulation Holding AB (publ) Stock
Stocks
ISR
SE0008212195
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Winqvist
CEO | Chief Executive Officer | 61 | 01/01/2018 |
Jonas Winqvist
DFI | Director of Finance/CFO | 57 | 01/01/2021 |
Johan Sjodahl
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 01/01/2016 | |
| Director/Board Member | 79 | 17/09/2015 | |
| Director/Board Member | - | 01/01/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -43.37% | - | - | 9.92M | |
| +1.10% | -2.67% | +62.79% | +70.47% | 67.53B | |
| +1.28% | +8.71% | +13.96% | +95.16% | 60.74B | |
| +0.36% | -0.95% | +20.09% | +99.04% | 55.66B | |
| -0.96% | +7.41% | +10.20% | +108.91% | 47.97B | |
| -1.25% | +2.35% | +22.74% | +38.34% | 45.24B | |
| -2.41% | -0.73% | +167.89% | +794.72% | 39.08B | |
| +1.21% | -2.56% | +20.27% | +52.81% | 35.34B | |
| -0.87% | -2.89% | +79.60% | +63.96% | 33.45B | |
| -2.22% | +8.56% | -39.26% | +397.14% | 26.49B | |
| Average | -0.38% | +3.27% | +39.81% | +191.17% | 46B | |
| Weighted average by Cap. | -0.17% | +3.39% | +40.40% | +166.70% |
Employees
5
